X-103776965-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_000533.5(PLP1):c.-31C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00149 in 1,197,630 control chromosomes in the GnomAD database, including 10 homozygotes. There are 543 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 2 hom., 62 hem., cov: 23)
Exomes 𝑓: 0.0014 ( 8 hom. 481 hem. )
Consequence
PLP1
NM_000533.5 5_prime_UTR
NM_000533.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.394
Genes affected
PLP1 (HGNC:9086): (proteolipid protein 1) This gene encodes a transmembrane proteolipid protein that is the predominant component of myelin. The encoded protein may play a role in the compaction, stabilization, and maintenance of myelin sheaths, as well as in oligodendrocyte development and axonal survival. Mutations in this gene cause Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Alternatively splicing results in multiple transcript variants, including the DM20 splice variant. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant X-103776965-C-T is Benign according to our data. Variant chrX-103776965-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 220658.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-103776965-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0019 (213/111817) while in subpopulation EAS AF= 0.0224 (79/3531). AF 95% confidence interval is 0.0184. There are 2 homozygotes in gnomad4. There are 62 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLP1 | NM_000533.5 | c.-31C>T | 5_prime_UTR_variant | 1/7 | ENST00000621218.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLP1 | ENST00000621218.5 | c.-31C>T | 5_prime_UTR_variant | 1/7 | 1 | NM_000533.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00183 AC: 204AN: 111767Hom.: 1 Cov.: 23 AF XY: 0.00177 AC XY: 60AN XY: 33973
GnomAD3 genomes
AF:
AC:
204
AN:
111767
Hom.:
Cov.:
23
AF XY:
AC XY:
60
AN XY:
33973
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00343 AC: 619AN: 180671Hom.: 3 AF XY: 0.00243 AC XY: 159AN XY: 65353
GnomAD3 exomes
AF:
AC:
619
AN:
180671
Hom.:
AF XY:
AC XY:
159
AN XY:
65353
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00144 AC: 1566AN: 1085813Hom.: 8 Cov.: 27 AF XY: 0.00136 AC XY: 481AN XY: 352643
GnomAD4 exome
AF:
AC:
1566
AN:
1085813
Hom.:
Cov.:
27
AF XY:
AC XY:
481
AN XY:
352643
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00190 AC: 213AN: 111817Hom.: 2 Cov.: 23 AF XY: 0.00182 AC XY: 62AN XY: 34033
GnomAD4 genome
AF:
AC:
213
AN:
111817
Hom.:
Cov.:
23
AF XY:
AC XY:
62
AN XY:
34033
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 19, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Sep 18, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 13, 2021 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Pelizaeus-Merzbacher disease, mild Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | OMIM | Jan 01, 1996 | - - |
Hereditary spastic paraplegia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 23, 2023 | - - |
Pelizaeus-Merzbacher disease;C1839264:Hereditary spastic paraplegia 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 25, 2022 | - - |
Pelizaeus-Merzbacher disease Benign:1
Benign, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The hemizygous c.-31C>T variant in PLP1 has been identified in a Japanese individual with Perlizaeus-Merzbacher disease (PMID: 8723686), and has been identified in >2% of East Asian chromosomes, 61 hemizygotes, and 1 homozygote by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for X-linked recessive Perlizaeus-Merzbacher disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at